Madhusudhan Reddy
Madhusudhan Reddy Gowravaram, Waltham, MA US
Patent application number | Description | Published |
---|---|---|
20110245224 | FUSED, SPIROCYCLIC HETEROAROMATIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS - The present invention relates to compounds of Formula (I); to pharmaceutically acceptable salts thereof, to methods of using them to treat bacterial infections, and to methods for their preparation. | 10-06-2011 |
20140128371 | CHEMICAL COMPOUNDS 542 - The present invention relates to compounds of Formula (I): | 05-08-2014 |
20140206677 | COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS - Compounds of formula (I), pharmaceutically acceptable salts thereof, and uses of the compounds of formula (I) for treating bacterial infections are disclosed. | 07-24-2014 |
20150203513 | COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS - Compounds of formula (I), pharmaceutically acceptable salts thereof, and uses of the compounds of formula (I) for treating bacterial infections are disclosed. | 07-23-2015 |
20150368266 | CHEMICAL COMPOUNDS 542 - The present invention relates to compounds of Formula (I): | 12-24-2015 |
Madhusudhan Reddy Gowravaram, Acton, MA US
Patent application number | Description | Published |
---|---|---|
20160130281 | COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS - Compounds of formula (I), pharmaceutically acceptable salts thereof, and uses of the compounds of formula (I) for treating bacterial infections are disclosed. | 05-12-2016 |
Madhusudhan Reddy Kollaredy, Andhra Pradesh IN
Patent application number | Description | Published |
---|---|---|
20140336073 | METHOD OF DETERMINATION OF CANCER CELL DRUG SENSITIVITY TOWARDS AURORA KINASE INHIBITORS - A method for determining the sensitivity and/or resistance of a patient suffering from a cancer disease to Aurora kinase inhibitor therapy, which comprises determining in vitro in the cancer cells or body fluids taken from the patient the expression of at least one gene selected from a particular group and/or determining in vitro in the cancer cells or body fluids taken from the patient the level of at least one protein selected from a particular group. | 11-13-2014 |